298 related articles for article (PubMed ID: 29161243)
1. The combined activation of K
Pillozzi S; D'Amico M; Bartoli G; Gasparoli L; Petroni G; Crociani O; Marzo T; Guerriero A; Messori L; Severi M; Udisti R; Wulff H; Chandy KG; Becchetti A; Arcangeli A
Br J Cancer; 2018 Jan; 118(2):200-212. PubMed ID: 29161243
[TBL] [Abstract][Full Text] [Related]
2. The role of hERG1 ion channels in epithelial-mesenchymal transition and the capacity of riluzole to reduce cisplatin resistance in colorectal cancer cells.
Fortunato A
Cell Oncol (Dordr); 2017 Aug; 40(4):367-378. PubMed ID: 28593575
[TBL] [Abstract][Full Text] [Related]
3. Naphtho[1,2-d]thiazol-2-ylamine (SKA-31), a new activator of KCa2 and KCa3.1 potassium channels, potentiates the endothelium-derived hyperpolarizing factor response and lowers blood pressure.
Sankaranarayanan A; Raman G; Busch C; Schultz T; Zimin PI; Hoyer J; Köhler R; Wulff H
Mol Pharmacol; 2009 Feb; 75(2):281-95. PubMed ID: 18955585
[TBL] [Abstract][Full Text] [Related]
4. Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury.
Chen CL; Liao JW; Hu OY; Pao LH
Arch Toxicol; 2016 Sep; 90(9):2249-2260. PubMed ID: 26438401
[TBL] [Abstract][Full Text] [Related]
5. Effects of Intermediate-Conductance Ca(2+)-Activated K(+) Channels on Human Endometrial Carcinoma Cells.
Zhang Y; Feng Y; Chen L; Zhu J
Cell Biochem Biophys; 2015 Jun; 72(2):515-25. PubMed ID: 25608633
[TBL] [Abstract][Full Text] [Related]
6. K
Bonito B; Sauter DR; Schwab A; Djamgoz MB; Novak I
Pflugers Arch; 2016 Nov; 468(11-12):1865-1875. PubMed ID: 27752766
[TBL] [Abstract][Full Text] [Related]
7. K⁺-channel inhibition reduces portal perfusion pressure in fibrotic rats and fibrosis associated characteristics of hepatic stellate cells.
Freise C; Heldwein S; Erben U; Hoyer J; Köhler R; Jöhrens K; Patsenker E; Ruehl M; Seehofer D; Stickel F; Somasundaram R
Liver Int; 2015 Apr; 35(4):1244-52. PubMed ID: 25212242
[TBL] [Abstract][Full Text] [Related]
8. New positive Ca2+-activated K+ channel gating modulators with selectivity for KCa3.1.
Coleman N; Brown BM; Oliván-Viguera A; Singh V; Olmstead MM; Valero MS; Köhler R; Wulff H
Mol Pharmacol; 2014 Sep; 86(3):342-57. PubMed ID: 24958817
[TBL] [Abstract][Full Text] [Related]
9. Novel phenolic inhibitors of small/intermediate-conductance Ca²⁺-activated K⁺ channels, KCa3.1 and KCa2.3.
Oliván-Viguera A; Valero MS; Murillo MD; Wulff H; García-Otín AL; Arbonés-Mainar JM; Köhler R
PLoS One; 2013; 8(3):e58614. PubMed ID: 23516517
[TBL] [Abstract][Full Text] [Related]
10. Activation of KCa3.1 by SKA-31 induces arteriolar dilatation and lowers blood pressure in normo- and hypertensive connexin40-deficient mice.
Radtke J; Schmidt K; Wulff H; Köhler R; de Wit C
Br J Pharmacol; 2013 Sep; 170(2):293-303. PubMed ID: 23734697
[TBL] [Abstract][Full Text] [Related]
11. IK1 channel activity contributes to cisplatin sensitivity of human epidermoid cancer cells.
Lee EL; Hasegawa Y; Shimizu T; Okada Y
Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1398-406. PubMed ID: 18367588
[TBL] [Abstract][Full Text] [Related]
12. Calcium-gated K
Tarasov MV; Bystrova MF; Kotova PD; Rogachevskaja OA; Sysoeva VY; Kolesnikov SS
Pflugers Arch; 2017 Feb; 469(2):349-362. PubMed ID: 28028617
[TBL] [Abstract][Full Text] [Related]
13. Calcium-dependent potassium channels control proliferation of cardiac progenitor cells and bone marrow-derived mesenchymal stem cells.
Vigneault P; Naud P; Qi X; Xiao J; Villeneuve L; Davis DR; Nattel S
J Physiol; 2018 Jun; 596(12):2359-2379. PubMed ID: 29574723
[TBL] [Abstract][Full Text] [Related]
14. Development of a QPatch automated electrophysiology assay for identifying KCa3.1 inhibitors and activators.
Jenkins DP; Yu W; Brown BM; Løjkner LD; Wulff H
Assay Drug Dev Technol; 2013; 11(9-10):551-60. PubMed ID: 24351043
[TBL] [Abstract][Full Text] [Related]
15. Influence of Kv11.1 (hERG1) K
Fernández-Villabrille S; Álvarez-González E; Barros F; de la Peña P; Sierra LM
Pflugers Arch; 2021 Feb; 473(2):197-217. PubMed ID: 33452554
[TBL] [Abstract][Full Text] [Related]
16. KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo.
D'Alessandro G; Catalano M; Sciaccaluga M; Chece G; Cipriani R; Rosito M; Grimaldi A; Lauro C; Cantore G; Santoro A; Fioretti B; Franciolini F; Wulff H; Limatola C
Cell Death Dis; 2013 Aug; 4(8):e773. PubMed ID: 23949222
[TBL] [Abstract][Full Text] [Related]
17. Correlation between potassium channel expression and sensitivity to drug-induced cell death in tumor cell lines.
Leanza L; O'Reilly P; Doyle A; Venturini E; Zoratti M; Szegezdi E; Szabo I
Curr Pharm Des; 2014; 20(2):189-200. PubMed ID: 23701546
[TBL] [Abstract][Full Text] [Related]
18. The inhibition of KCa3.1 channels activity reduces cell motility in glioblastoma derived cancer stem cells.
Ruggieri P; Mangino G; Fioretti B; Catacuzzeno L; Puca R; Ponti D; Miscusi M; Franciolini F; Ragona G; Calogero A
PLoS One; 2012; 7(10):e47825. PubMed ID: 23110108
[TBL] [Abstract][Full Text] [Related]
19. Histone Deacetylases Enhance Ca
Matsui M; Terasawa K; Kajikuri J; Kito H; Endo K; Jaikhan P; Suzuki T; Ohya S
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30262728
[TBL] [Abstract][Full Text] [Related]
20. K
Robles-Martínez L; Garay E; Martel-Gallegos MG; Cisneros-Mejorado A; Pérez-Montiel D; Lara A; Arellano RO
Sci Rep; 2017 Jun; 7(1):4340. PubMed ID: 28659615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
